Answers are grounded in this paper and cite their sources.
Participants with OSA and type 2 diabetes mellitus receiving ILI for weight loss had reduced OSA severity at 10 years. No difference in OSA severity was present between ILI and DSE groups at 10 years. Improvement in OSA severity over the 10-year period with ILI was related to change in body weight, baseline AHI, and intervention independent of weight change.
No takes yet. Share an insight, caveat, or question.
Kuna et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: